Azithromycin reverses airflow obstruction in established bronchiolitis obliterans syndrome

American Journal of Respiratory and Critical Care Medicine

Volumn 172, Issue 6, 2005, Pages 772-775

  Yates, Bryan ^a   Murphy, Desmond M ^a   Forrest, Ian A ^a   Ward, Chris ^a   Rutherford, Robert M ^a   Fisher, Andrew J ^a   Lordan, James L ^a   Dark, John H ^a   Corris, Paul A ^a  

^a FREEMAN HOSPITAL   (United Kingdom)

Author keywords

Lung; Macrolide; Transplantation

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; AZITHROMYCIN; CALCINEURIN INHIBITOR; CORTICOSTEROID; CYCLOSPORIN; IMMUNOSUPPRESSIVE AGENT; MACROLIDE; MYCOPHENOLIC ACID; PREDNISOLONE; TACROLIMUS;

ADOLESCENT; ADULT; AIRWAY OBSTRUCTION; ALPHA 1 ANTITRYPSIN DEFICIENCY; ANTIBIOTIC THERAPY; ARTICLE; BRONCHIECTASIS; BRONCHIOLITIS OBLITERANS; CLINICAL ARTICLE; CYSTIC FIBROSIS; DRUG MECHANISM; EMPHYSEMA; FEMALE; FOLLOW UP; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LOW DRUG DOSE; LUNG FIBROSIS; LUNG FUNCTION; LUNG GRAFT REJECTION; LUNG SARCOIDOSIS; LUNG TRANSPLANTATION; MALE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; RETROSPECTIVE STUDY; TREATMENT OUTCOME;

ADULT; AIRWAY OBSTRUCTION; ANTI-BACTERIAL AGENTS; AZITHROMYCIN; BRONCHIOLITIS OBLITERANS; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; LUNG; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; SYNDROME; TREATMENT OUTCOME;

EID: 24944510360     PISSN: 1073449X     EISSN: None     Source Type: Journal    
DOI: 10.1164/rccm.200411-1537OC     Document Type: Article

References (37)

1. Arcasoy SM, Kotloff RM. Lung transplantation. N Engl J Med 1999;340:1081-1091.
2. Sharples LD, McNeil K, Stewart S, Wallwork J. Risk factors for bronchiolitis obliterans: a systematic review of recent publications. J Heart Lung Transplant 2002;21:271-281.
3. Ross DJ, Marchevsky A, Kramer M, Kass RM. "Refractoriness" of airflow obstruction associated with isolated lymphocytic bronchiolitis/ bronchitis in pulmonary allografts. J Heart Lung Transplant 1997;16:832-838.
4. Ward C, Snell GI, Zheng L, Orsida B, Whitford H, Williams TJ, Walters EH. Endobronchial biopsy and bronchoalveolar lavage in stable lung transplant recipients and chronic rejection. Am J Respir Crit Care Med 1998;158:84-91.
5. Ward C, Snell GI, Orsida B, Zheng L, Williams TJ, Walters EH. Airway versus transbronchial biopsy and BAL in lung transplant recipients: different but complementary. Eur Respir J 1997;10:2876-2880.
6. Ward C, Whitford H, Snell G, Bao H, Zheng L, Reid D, Williams TJ, Walters EH. Bronchoalveolar lavage macrophage and lymphocyte phenotypes in lung transplant recipients. J Heart Lung Transplant 2001;20:1064-1074.
7. Ward C, De Soyza A, Fisher AJ, Pritchard G, Forrest IA, Corris PA. Reticular basement membrane thickening in airways of lung transplant recipients is not affected by inhaled corticosteroids. Clin Exp Allergy 2004;34:1905-1909.
8. DiGiovine B, Lynch JP III, Martinez FJ, Flint A, Whyte RI, Iannettoni MD, Arenberg DA, Burdick MD, Glass MC, Wilke CA, Morris SB, Kunkel SI, Strieter RM. Bronchoalveolar lavage neutrophilia is associated with obliterative bronchiolitis after lung transplantation: role of IL-8. J Immunol 1996;157:4194-4202.
9. Boehler A, Estenne M. Obliterative bronchiolitis after lung transplantation. Curr Opin Pulm Med 2000;6:133-139.
10. Corris PA. Bronchiolitis obliterans syndrome. Chest Surg Clin N Am 2003;13:543-557.
11. Ouwens JP, van der Mark TW, Koeter GH, de Boer WJ, Grevink RG, van der Bij W. Bronchiolar airflow impairment after lung transplantation: an early and common manifestation. J Heart Lung Transplant 2002;21:1056-1061.
12. Hertz MI, Mohacsi PJ, Boucek MM, Taylor DO, Trulock EP, Deng MC, Rowe AW. The Registry of the International Society for Heart and Lung Transplantation: past, present and future. J Heart Lung Transplant 2002;21:945-949.
13. Estenne M, Maurer JR, Boehler A, Egan JJ, Frost A, Hertz M, Mallory GB, Snell GI, Yousem S. Bronchiolitis obliterans syndrome 2001: an update of the diagnostic criteria. J Heart Lung Transplant 2002;21:297-310.
14. Fisher AJRR, Bozzino J, Parry G, Dark JH, Corris PA. The safety and efficacy of total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation. Am J Transplant (In press)
15. Borger P, Kauffman HF, Timmerman JA, Scholma J, van den Berg JW, Koeter GH. Cyclosporine, FK506, mycophenolate mofetil, and prednisolone differentially modulate cytokine gene expression in human airway-derived epithelial cells. Transplantation 2000;69:1408-1413.
16. Briffa N, Morris RE. New immunosuppressive regimens in lung transplantation. Eur Respir J 1997;10:2630-2637.
17. Hojo M, Morimoto T, Maluccio M, Asano T, Morimoto K, Lagman M, Shimbo T, Suthanthiran M. Cyclosporine induces cancer progression by a cell-autonomous mechanism. Nature 1999;397:530-534.
18. Muraoka K, Fujimoto K, Sun X, Yoshioka K, Shimizu K, Yagi M, Bose H Jr, Miyazaki I, Yamamoto K. Immunosuppressant FK506 induces interleukin-6 production through the activation of transcription factor nuclear factor (NF)-kappa(B): implications for FK506 nephropathy. J Clin Invest 1996;97:2433-2439.
19. Zhang JG, Walmsley MW, Moy JV, Cunningham AC, Talbot D, Dark JH, Kirby JA. Differential effects of cyclosporin A and tacrolimus on the production of TGF-beta: implications for the development of obliterative bronchiolitis after lung transplantation. Transpl Int 1998;11: S325-S327.
20. Equi A, Balfour-Lynn IM, Bush A, Rosenthal M. Long term azithromycin in children with cystic fibrosis: a randomised, placebo-controlled crossover trial. Lancet 2002;360:978-984.
21. Everard ML, Sly P, Brenan S, Ryan G. Macrolide antibiotics in diffuse panbronchiolitis and in cystic fibrosis. Eur Respir J 1997;10:2926.
22. Gorrini M, Lupi A, Viglio S, Pamparana F, Cetta G, Iadarola P, Powers JC, Luisetti M. Inhibition of human neutrophil elastase by erythromycin and flurythromycin, two macrolide antibiotics. Am J Respir Cell Mol Biol 2001;25:492-499.
23. Ordonez CL, Stulbarg M, Grundland H, Liu JT, Boushey HA. Effect of clarithromycin on airway obstruction and inflammatory markers in induced sputum in cystic fibrosis: a pilot study. Pediatr Pulmonol 2001;32:29-37.
24. Shimane T, Asano K, Suzuki M, Hisamitsu T, Suzaki H. Influence of a macrolide antibiotic, roxithromycin, on mast cell growth and activation in vitro. Mediators Inflamm 2001;10:323-332.
25. Spencer D. Macrolide antibiotics in diffuse panbronchiolitis and in cystic fibrosis. Eur Respir J 1998;11:1428.
26. Gotfried MH. Macrolides for the treatment of chronic sinusitis, asthma, and COPD. Chest 2004;125:52S-60S.
27. Gerhardt SG, McDyer JF, Girgis RE, Conte JV, Yang SC, Orens JB. Maintenance azithromycin therapy for bronchiolitis obliterans syndrome: results of a pilot study. Am J Respir Crit Care Med 2003;168:121-125.
28. Verleden GM, Dupont LJ. Azithromycin therapy for patients with bronchiolitis obliterans syndrome after lung transplantation. Transplantation 2004;77:1465-1467.
29. Yates B, Ward C, Murphy D, Forrest I, Fisher AJ, Lordan J, Dark JH, Corris PA. Azithromycin reverses airflow obstruction in established Bronchiolitis Obliterans Syndrome (BOS) following lung transplantation. J Heart Lung Transplant 2005;24:S102.
30. Yates B, Ward C, Murphy D, Forrest I, Fisher AJ, Lordan J, Dark JH, Corris PA. Azithromycin reverses airflow obstruction in established Bronchiolitis Obliterans Syndrome (BOS) following lung transplantation. Proc Am Thorac Soc 2005;2:A893.
31. Takizawa H, Desaki M, Ohtoshi T, Kawasaki S, Kohyama T, Sato M, Tanaka M, Kasama T, Kobayashi K, Nakajima J, Ito K. Erythromycin modulates IL-8 expression in normal and inflamed human bronchial epithelial cells. Am J Respir Crit Care Med 1997;156:266-271.
32. Yamasawa H, Oshikawa K, Ohno S, Sugiyama Y. Macrolides inhibit epithelial cell-mediated neutrophil survival by modulating GM-CSF release. Am J Respir Cell Mol Biol 2004;30:569-575.
33. Kanai K, Asano K, Hisamitsu T, Suzaki H. Suppression of matrix metalloproteinase production from nasal fibroblasts by macrolide antibiotics in vitro. Eur Respir J 2004;23:671-678.
34. Schultz MJ. Macrolide activities beyond their antimicrobial effects: macrolides in diffuse panbronchiolitis and cystic fibrosis. J Antimicrob Chemother 2004;54:21-28.
35. Tateda K, Comte R, Pechere JC, Kohler T, Yamaguchi K, Van Delden C. Azithromycin inhibits quorum sensing in Pseudomonas aeruginosa. Antimicrob Agents Chemother 2001;45:1930-1933.
36. Redmund KF GZ, Hofer M, Reichsteiner T, Vogt P, Russi EW, Boehler A. Clarithromycin has a preventative effect on chronic graft rejection [abstract]. Eur Respir J 2004;24:465s.
37. Estenne M, Hertz MI. Bronchiolitis obliterans after human lung transplantation. Am J Respir Crit Care Med 2002;166:440-444.